Sponsored By

News Desk: Industry Responds to Warning Letters on DMBA

FDA recently issued 14 warning letters to supplement companies selling products containing DMBA, a potentially harmful stimulant. The administration ordered the companies to discontinue distribution of these products immediately. FDA declared it will take additional action if the potentially dangerous DMBA-containing products are not taken off of the market. Watch this INSIDER News Desk for more coverage, and also check out regulatory editor Josh Long's post, "FDA Issues 14 Warning Letters on DMBA to Supplement Companies," for a full report of the event.

May 8, 2015

FDA recently issued 14 warning letters to supplement companies selling products containing DMBA, a potentially harmful stimulant. FDA ordered the companies to discontinue distribution of these products immediately. FDA declared it will take additional action if the potentially dangerous DMBA-containing products are not taken off of the market.

Watch this INSIDER News Desk for more coverage, and also check out regulatory editor Josh Long's post, "FDA Issues 14 Warning Letters on DMBA to Supplement Companies," for a full report of the event.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like